A high-quality, open access journal edited by experts in diabetes and endocrinology. Published by BMJ in partnership with the American Diabetes Association.
Associations of body weight and COVID-19 with autoimmunity in pediatric new-onset type 1 diabetes: results from the prospective DPV registry
Learn more 👉 bit.ly/3LIk3UC
Metabolic factors moderate the association between hepatic fibrosis and atherosclerotic cardiovascular risk in type 2 diabetes (T2D)
Learn more:
👉 bit.ly/49k3FmN
Serum soluble ASGR1 concentration is elevated in patients with metabolic dysfunction-associated steatotic liver disease and is associated with adiponectin
Learn more 👇
bit.ly/4qeQWXc
Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity
Follow this link to review the latest guidance from the American Diabetes Association (ADA) on pharmacologic management of obesity in adults
👉 bit.ly/4teuznj
Effects of benfotiamine treatment over 12 months on morphometric, neurophysiological and clinical measures in type 2 diabetes patients with symptomatic polyneuropathy: a randomized, placebo-controlled, double-blind clinical trial (BOND study)
👀 Read the full paper here: bit.ly/3Z0zaM8
Zero Dollar Drug Copay program improves antidiabetic medication adherence and medication use patterns among Blue Cross and Blue Shield of Louisiana members with diabetes in Louisiana
Learn more 👇
bit.ly/4rggfZT
Associations of body weight and COVID-19 with autoimmunity in pediatric new-onset type 1 diabetes: results from the prospective DPV registry
Learn more 👉 bit.ly/3LIk3UC
Metal mixture inflammatory index and diabetes risk in US adults: a cross-sectional analysis of NHANES 1999-2020 and development of a LASSO-based prediction model
Learn more 👉 bit.ly/3YZl6Cx
Trends in delaying and forgoing medical care due to cost and the association with insurance status among US adults with diabetes, 2009-2023
👀 bit.ly/49IlGuv
HOT OFF THE PRESS!
Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity
Follow this link to review the brand new recommendations from the American Diabetes Association (ADA) on pharmacologic management of obesity in adults
👉
Identifying interhospital variation in hyperosmolar hyperglycemic syndrome (HHS) care: development and outcomes of the DEKODE HHS model
👇 Learn more
bit.ly/4pDMn9g
Combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists in heart failure patients with type 2 diabetes (T2D)
Learn more 👉 bit.ly/489r60P
Metabolic factors moderate the association between hepatic fibrosis and atherosclerotic cardiovascular risk in type 2 diabetes (T2D)
Learn more:
👉 bit.ly/49k3FmN